Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.
Herman, T S
Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. [electronic resource] - Cancer research May 1988 - 2693-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0008-5472
Animals
Cell Survival--drug effects
Cisplatin--therapeutic use
Combined Modality Therapy
Fibrosarcoma--pathology
Hyperthermia, Induced
Male
Mice
Mice, Inbred C3H
Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. [electronic resource] - Cancer research May 1988 - 2693-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0008-5472
Animals
Cell Survival--drug effects
Cisplatin--therapeutic use
Combined Modality Therapy
Fibrosarcoma--pathology
Hyperthermia, Induced
Male
Mice
Mice, Inbred C3H